Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Visa
V
|
+$2.17B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.84B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.36B |
| 4 |
Linde
LIN
|
+$743M |
| 5 |
DuPont de Nemours
DD
|
+$592M |
Top Sells
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.5B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$311M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$281M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
IAC Inc
IAC
|
+$239M |
Sector Composition
| 1 | Technology | 17.81% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.06% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOHU
2626
Sohu.com
SOHU
$467M
| $225K | ﹤0.01% |
11,365
-1,484
| -12% | -$29.4K |
|
2627
UNIFI
UFI
$83.4M
| $225K | ﹤0.01% |
17,574
+4,558
| +35% | +$58.4K |
|
|
BEST
2628
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $225K | ﹤0.01% |
3,750
+1,640
| +78% | +$98.4K |
|
2629
Brookdale Senior Living
BKD
$1.78B
| $224K | ﹤0.01% |
87,812
-19,921
| -18% | -$50.8K |
|
|
QADA
2630
DELISTED
QAD Inc.
QADA
| $224K | ﹤0.01% |
5,310
-1,055
| -17% | -$44.5K |
|
2631
Crinetics Pharmaceuticals
CRNX
$3.18B
| $223K | ﹤0.01% |
14,241
-2,547
| -15% | -$39.9K |
|
2632
Old Republic International
ORI
$9.91B
| $222K | ﹤0.01% |
15,039
-60,208
| -80% | -$889K |
|
2633
Scholar Rock
SRRK
$3.24B
| $222K | ﹤0.01% |
12,555
+23
| +0.2% | +$407 |
|
2634
VirnetX
VHC
$72.4M
| $222K | ﹤0.01% |
2,117
-266
| -11% | -$27.9K |
|
|
GTHX
2635
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $222K | ﹤0.01% |
19,298
-4,606
| -19% | -$53K |
|
|
BCLI
2636
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $221K | ﹤0.01% |
872
-106
| -11% | -$26.9K |
|
|
MESO
2637
Mesoblast
MESO
$1.98B
| $221K | ﹤0.01% |
5,950
+5,500
| +1,222% | +$204K |
|
2638
Fonar
FONR
$97.7M
| $220K | ﹤0.01% |
10,512
-2,968
| -22% | -$62.1K |
|
2639
Replimune Group
REPL
$443M
| $220K | ﹤0.01% |
9,550
-1,401
| -13% | -$32.3K |
|
2640
B. Riley Financial
RILY
$198M
| $219K | ﹤0.01% |
8,731
-2,347
| -21% | -$58.9K |
|
2641
KALA BIO
KALA
$135M
| $218K | ﹤0.01% |
575
-2,620
| -82% | -$993K |
|
|
CBL
2642
DELISTED
CBL& Associates Properties, Inc.
CBL
| $218K | ﹤0.01% |
1,355,606
+1,349,384
| +21,687% | +$217K |
|
2643
Sterling Infrastructure
STRL
$9.82B
| $217K | ﹤0.01% |
15,313
-2,523
| -14% | -$35.8K |
|
2644
iRadimed
IRMD
$911M
| $216K | ﹤0.01% |
10,169
-2,753
| -21% | -$58.5K |
|
2645
Origin Bancorp
OBK
$1.1B
| $216K | ﹤0.01% |
10,071
-2,004
| -17% | -$43K |
|
2646
SM Energy
SM
$3B
| $216K | ﹤0.01% |
136,008
-89,923
| -40% | -$143K |
|
2647
Prothena Corp
PRTA
$439M
| $215K | ﹤0.01% |
21,409
-6,757
| -24% | -$67.9K |
|
|
AKTS
2648
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $215K | ﹤0.01% |
26,377
-2,830
| -10% | -$23.1K |
|
2649
Pembina Pipeline
PBA
$22.4B
| $214K | ﹤0.01% |
10,033
-3,823
| -28% | -$81.5K |
|
2650
Ceco Environmental
CECO
$1.74B
| $213K | ﹤0.01% |
29,274
-5,309
| -15% | -$38.6K |
|